Crypto World
Guardant Health Stock Dives After Losing A Patent Dispute; Judge Orders Royalties
Guardant Health (GH) stock tumbled Monday after losing a patent battle against privately held TwinStrand Biosciences and the University of Washington. The judge ordered Guardant to pay more than $245.2 million in damages, accrued royalty and interest. Guardant will also have to pay a 6% royalty on sales of key products, including its Guardant360 and Shield tests. These tests use…
Copyright ©2026 Investor’s Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8
You must be logged in to post a comment Login